Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» SteadyMed
SteadyMed
United axes PAH program Trevyent, once bought for cheap in acquisition of a rival, after FDA feedback
Endpoints
Wed, 03/3/21 - 10:57 am
United Therapeutics
Trevyent
PAH
SteadyMed
4 Biotech and Pharma Stocks Projected to Rise 50% to 100%
24/7 Wall St
Sun, 04/19/15 - 11:45 am
Flex Pharma
Intercept Pharmaceuticals
Intra-Cellular Therapies
SteadyMed
Drug-device biotech SteadyMed swings for a $55M IPO
Fierce Biotech
Mon, 02/9/15 - 09:07 pm
devices
SteadyMed
IPOs
biotech
PAH